PROFUND ADVISORS LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 268 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$376,075
-4.6%
12,258
+24.5%
0.02%0.0%
Q2 2023$394,409
-6.8%
9,843
-5.1%
0.02%
-19.2%
Q1 2023$423,077
+82.5%
10,367
+72.7%
0.03%
+73.3%
Q4 2022$231,814
-30.8%
6,004
-4.7%
0.02%
-37.5%
Q3 2022$335,000
-13.7%
6,300
-5.2%
0.02%
-4.0%
Q2 2022$388,000
-31.0%
6,647
-9.7%
0.02%
+4.2%
Q1 2022$562,000
+29.2%
7,364
+1.9%
0.02%
+71.4%
Q4 2021$435,000
+9.6%
7,224
+1.8%
0.01%
+7.7%
Q3 2021$397,000
-18.5%
7,096
-11.5%
0.01%
-18.8%
Q2 2021$487,000
-7.1%
8,018
+7.3%
0.02%
-20.0%
Q1 2021$524,000
+8.3%
7,470
-7.6%
0.02%
-4.8%
Q4 2020$484,000
+28.0%
8,086
+28.6%
0.02%
+10.5%
Q3 2020$378,000
+8.0%
6,287
-5.9%
0.02%0.0%
Q2 2020$350,000
+6.1%
6,678
-8.3%
0.02%
+35.7%
Q4 2019$330,000
+16.2%
7,279
-2.5%
0.01%0.0%
Q3 2019$284,000
+6.8%
7,463
+20.6%
0.01%
-12.5%
Q4 2018$266,000
-39.5%
6,187
-30.9%
0.02%
-5.9%
Q3 2018$440,000
+50.7%
8,960
+135.9%
0.02%
+21.4%
Q4 2015$292,000
-20.0%
3,799
-26.5%
0.01%
-6.7%
Q2 2015$365,000
-18.7%
5,166
+2.3%
0.02%
-11.8%
Q1 2015$449,000
+10.3%
5,052
+10.2%
0.02%0.0%
Q4 2014$407,000
-2.6%
4,585
+6.4%
0.02%
-15.0%
Q3 2014$418,000
+63.9%
4,308
+55.2%
0.02%
+81.8%
Q2 2014$255,0002,7750.01%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders